Organization: Health Canada
Year: 2024
Month: June
Request Number: A-2021-001879
Request Summary: Among the “submissions currently under review: supplemental new drug submissions for new uses”, there are two filings of IncobotulinumtoxinA by Merz Pharmaceuticals GmbH, accepted in May-2021 and November-2021. The Screening Acceptance Letters for each submission
Disposition: Disclosed in part
Number of pages: 3